These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 1663149)
1. An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma. Shigemasa C; Kouchi T; Yoshida A; Mashiba H J Med; 1991; 22(3):187-93. PubMed ID: 1663149 [TBL] [Abstract][Full Text] [Related]
2. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. Hirohara D; Nomura K; Okamoto T; Ujihara M; Takano K J Clin Endocrinol Metab; 2001 Sep; 86(9):4292-8. PubMed ID: 11549664 [TBL] [Abstract][Full Text] [Related]
3. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385 [TBL] [Abstract][Full Text] [Related]
4. Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. Nomura K; Toraya S; Horiba N; Ujihara M; Aiba M; Demura H J Clin Endocrinol Metab; 1992 Jul; 75(1):323-7. PubMed ID: 1619026 [TBL] [Abstract][Full Text] [Related]
5. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma. Mune T; Morita H; Yasuda K; Yamakita N; Miura K J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449 [TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration. Ganguly A; Luetscher JA; Weinberger MH Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813 [TBL] [Abstract][Full Text] [Related]
7. Regulation of aldosterone secretion in primary aldosteronism. Vetter H; Vetter W Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of primary hyperaldosteronism]. Diederich S; Bidlingmaier M; Quinkler M; Reincke M Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347 [TBL] [Abstract][Full Text] [Related]
9. Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism. Fallo F; Chouman M; Pagotto U; Pistorello M Miner Electrolyte Metab; 1991; 17(3):185-9. PubMed ID: 1779941 [TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism. Brown RD; Kem DC; Hogan MJ; Hegstad RL Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946 [TBL] [Abstract][Full Text] [Related]
12. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism. Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003 [TBL] [Abstract][Full Text] [Related]
13. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. Biglieri EG; Schambelan M J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820 [TBL] [Abstract][Full Text] [Related]
14. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism. Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor. Carey RM; Sen S; Dolan LM; Malchoff CD; Bumpus FM N Engl J Med; 1984 Jul; 311(2):94-100. PubMed ID: 6330549 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F; J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone regulation in primary aldosteronism: differences between adenoma and bilateral hyperplasia. Mantero F; Gion M; Armanini D; Opocher G Clin Sci Mol Med Suppl; 1976 Dec; 3():329s-332s. PubMed ID: 192515 [TBL] [Abstract][Full Text] [Related]
18. Single dose captopril as a diagnostic test for primary aldosteronism. Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726 [TBL] [Abstract][Full Text] [Related]
19. Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas. Fallo F; Barzon L; Biasi F; Altavilla G; Boscaro M; Sonino N Exp Clin Endocrinol Diabetes; 1998; 106(1):74-8. PubMed ID: 9516064 [TBL] [Abstract][Full Text] [Related]
20. ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism. Wenting GJ; Man in't Veld AJ; Derkx FH; Brummelen PV; Schalekamp MA J Clin Endocrinol Metab; 1978 Feb; 46(2):326-35. PubMed ID: 220277 [No Abstract] [Full Text] [Related] [Next] [New Search]